2017

img1
Norilsk Nickel
800 bln. RUR
 will be spent on  production modernization until 2020
More
img1
Rosa Khutor
94 km
the length of the ski slopes in 2017
More

The year 2017 starts with Rosa Khutor resort winning 13th place in the Top 100 most popular tourist brands of Russia rating, with the number of tourists exceeding 800 thousand people during the winter season. Nornikel gets the award from the Russian Ministry of Environment for its active policy in the sphere of environmental protection, and is ranked by WWF among the leaders of the rating of environmental performance of Russian mining companies. Petrovax Pharm starts building a new production line, investing in it more than 900 million rubles. Nornickel launches its «Sulfur project» in the Polar Division. In May, Nornickel together with the Vladimir Potanin Foundation creates Norilsk Development Agency. In September, the fiber-optic communication line 956 km long, laid from Novy Urengoy to Norilsk, brings broadband Internet to the world’s northernmost big city. The cost of the project — 2.5 billion rubles. In October, Nornickel starts commissioning at Bystrinsky GOK. In the middle of the month, the first batches of the drug localized with Beringer Ingelheim for the treatment of acute myocardial infarction are available for patients in Russia. And by the end of October Petrovax Pharm confirms the compliance of the quality management system with the requirements of ISO 9001: 2015. In addition to the main certificate, Petrovax Pharm receives a certificate of the unified international standard IQNet. For the 5th year in a row, Rosa Khutor becomes the winner of the World Ski Awards as the best resort in Russia and wins the title of the «brand of the year» within the first national Award in the field of hospitality «Golden Prometheus». Brand Finance Consulting Company publishes the world rating of mining and metallurgical companies ' brands. The only representative of Russia in the list is «Norilsk Nickel», the brand is estimated at $675 million. «Polyoxidonium» wins the 6th annual award of the Russian Pharma Awards 2017 in the nomination «Medication of choice for the treatment and prevention of ARVI and influenza in children».